Skip to Content
Merck
CN

L3045

β-Lactamase from Pseudomonas fluorescens

lyophilized powder, recombinant, expressed in E. coli

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

UNSPSC Code:
12352204
NACRES:
NA.54
EC Number:
MDL number:
Recombinant:
expressed in E. coli
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

recombinant

expressed in E. coli

form

lyophilized powder

enzyme activity

7.5-15 units/mg solid

shipped in

wet ice

storage temp.

2-8°C

Quality Level

Physical form

Lyophilized powder containing potassium phosphate and sodium bicarbonate

Other Notes

One unit will hydrolyze 1.0 μmole of benzylpenicillin per minute at pH 7.0 at 25 °C

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

常规特殊物品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Teerawit Tangkoskul et al.
The Southeast Asian journal of tropical medicine and public health, 43(6), 1461-1469 (2013-02-19)
We performed extended-spectrum beta-lactamase (ESBL) phenotypic testing and molecular characterization of three ESBL genes (TEM, SHV and CTX-M) and susceptibility testing by Clinical Laboratory Standards Institute (CLSI) disk diffusion method against three cephalosporins (ceftriaxone, ceftazidime, cefepime) and a cephamycin (cefoxitin)
Hasan Nazik et al.
The Southeast Asian journal of tropical medicine and public health, 43(5), 1178-1185 (2013-02-26)
Bacterial isolates producing Class D OXA-48 carbapenemase may be missed in routine laboratory testing, allowing them to spread undetected. The purpose of the present study was to detect bla(OXA-48) among ESBL-producing Klebsiella pneumoniae and Escherichia coli isolates collected from a
Seung Bok Hong et al.
Journal of medical microbiology, 62(Pt 6), 836-844 (2013-03-23)
The co-existence of carbapenemase, 16S rRNA methylase and mutated quinolone resistance-determining regions (QRDRs) can cause serious difficulty in treating infections with multidrug-resistant Acinetobacter baumannii. In this study, we aimed to determine the mechanisms of imipenem, amikacin and ciprofloxacin resistance in
MMWR. Morbidity and mortality weekly report, 62(6), 108-108 (2013-02-15)
On August 16, 2012, the Colorado Department of Public Health and Environment was notified of two patients at an acute-care hospital in Denver with carbapenem-resistant Enterobacteriaceae (CRE), specifically Klebsiella pneumoniae (CRKP), isolated from respiratory specimens during July-August. Both isolates produced
Chanapai Chaiyakulsil et al.
Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 95 Suppl 12, S138-S141 (2013-03-22)
Extended-spectrum beta-lactamase (ESBL) producing organisms cause wide spectrum of diseases including urinary tract infection, cholangitis, intra-abdominal abscess or pneumonia but rarely meningitis. The present report a successful nonsurgical, medical treatment in a child with Escherichia coli ESBL meningitis with acute

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service